This study was designed to determine the usefulness of coronary computed tomography angiography (CTA) in patients with acute chest pain.
these patients are admitted to the hospital for up to 24 h and undergo serial ECG and troponin testing, as well as a stress test to rule out acute coronary syndrome (ACS), at a cost in excess of $8 billion annually (8 -10) .
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Coronary computed tomography angiography (CTA) is a rapid diagnostic test that has the unique ability to noninvasively and accurately detect significant coronary artery stenoses (11) and coronary atherosclerotic plaque (12, 13) . Several smaller studies (14 -17) suggest that coronary CTA may be helpful to facilitate early triage in patients with acute chest pain. However, the distribution of CTA findings of coronary artery diseases (CAD) such as plaque and stenosis and their association with ACS is not established. Such knowledge would provide the basis for the assessment of the clinical utility of and the economic implications for using coronary CTA as an early triage tool. Thus, we conducted a prospective observational cohort study to assess the usefulness of coronary CTA in patients with acute chest pain who are being admitted with low to intermediate risk for ACS.
Methods
Patient population. The patient population of the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial consisted of patients who had a chief complaint of acute chest pain lasting Ͼ5 min during the past 24 h, normal initial troponin, and an initial ECG without evidence of myocardial ischemia. In all patients, ED physicians had sufficient clinical suspicion for an ischemic origin of chest pain and admitted these patients to the hospital to rule out ACS. Notably, patients with a history of established CAD, defined as stent implantation or coronary artery bypass grafting, were excluded. Detailed inclusion and exclusion criteria are provided in Table 1 .
We screened patients who presented with a chief complaint of chest pain to the ED on weekdays from 7 AM to 7 PM (May 2005 to May 2007). All eligible patients who agreed to participate underwent contrast-enhanced coronary CTA before admission to the hospital floor. All physicians, including those in the ED, who were involved in the standard clinical care of the patients remained blinded to the result of coronary CTA. The institutional review board approved the study protocol, and all patients provided written informed consent. Coronary CTA. The computed tomography (CT) imaging was performed using a 64-slice CT scanner (Sensation 64, Siemens Medical Solutions, Forchheim, Germany). In preparation for the scan, patients with a heart rate Ͼ60 beats/min received an intravenous beta-blocker (metoprolol, 5 to 20 mg) unless their systolic blood pressure was Ͻ100 mm Hg or other contraindications were present. In addition, patients received 0.6 mg of sublingual nitroglycerin.
All image acquisitions were performed during a single breathhold in inspiration.
Per standard protocol, a test bolus of 20 ml contrast agent was administered with a flow rate of 5 ml/s to determine the optimal timing of contrast injection. Coronary CTA datasets were acquired with 64 ϫ 0.6 mm slice collimation, a gantry rotation time of 330 ms, tube voltage of 120 kV, and an effective tube current of 850 mAs using ECGcorrelated tube current modulation when appropriate (18) . Contrast agent (80 to 100 ml, iodhexodol 320 mg/cm 3 , Visipaque, General Electrics Healthcare, Princeton, New Jersey) was injected intravenously at a rate of 5 ml/s to ensure homogeneous enhancement of the entire coronary artery tree.
Axial images were reconstructed with a slice thickness of 0.75 mm and increment of 0.4 mm using a retrospectively ECG-gated half-scan algorithm with a temporal resolution of 165 ms. Images were initially reconstructed at 60%, 65%, 70%, and 35% of the cardiac cycle (19) . Additional reconstructions were performed to minimize motion artifacts if necessary. All reconstructions were transferred to an offline workstation for analysis (Leonardo, Siemens Medical Solutions, Forchheim, Germany). Assessment of presence and extent of CAD by coronary CTA. Assessment of coronary CTA datasets for the presence of significant coronary stenosis and the presence of coronary atherosclerotic plaque was performed as a consensus reading by 2 experienced investigators (U.H./M.F. or F.B./M.D.S.) blinded to the subject's clinical presentation and history using a modified 17-segment model of the coronary artery tree (20, 21) . If a consensus could not be reached, a third expert reader (S.A.) made the final diagnosis. This method has been demonstrated to be highly reproducible (17) . Coronary atherosclerotic plaque. The presence of any coronary atherosclerotic plaque per segment, whether calcified or noncalcified, was determined as described previously (12, 13) . Briefly, noncalcified plaque was defined as any discernible structure that could be assigned to the coronary artery wall and had CT attenuation below the contrastenhanced coronary lumen but above the surrounding connective tissue/epicardial fat. Calcified plaque was defined as any structure with a CT attenuation of Ͼ130 HU that could be visually distinguished from the contrast-enhanced coronary lumen. Coronary artery stenosis. The presence of coronary artery stenosis was defined as a luminal obstruction Ͼ50% diameter in any coronary segment. If image quality did not permit definite exclusion of the presence of a significant stenosis (owing to the presence of motion artifacts, calcification, or low contrast-to-noise ratio), the segment was classified as indeterminate. For calculation of diagnostic accuracy, such cases were counted as positive.
Clinical End Points
ACS during index hospitalization. We defined ACS as either an acute myocardial infarction (MI) (i.e., patients developed a positive troponin during serial testing [6 h or 9 h after ED presentation] or unstable angina pectoris [UAP] according to the American Heart Association/ American College of Cardiology/European Society of Cardiology guidelines (22) (23) (24) . We defined UAP as clinical symptoms suggestive of ACS (unstable pattern of chest pain at rest, new onset, or crescendo angina), optimally with objective evidence of myocardial ischemia, such as a positive stress test. Major adverse cardiac events (MACE) during followup. A standardized follow-up phone call was conducted 6 months after enrollment to determine the occurrence of MACE (death, MI, and coronary revascularization). In addition, we retrieved medical records for all patients to verify all events potentially corresponding to a MACE, such as a report of recurrent symptoms resulting in medical consultation, diagnostic testing, or hospital admissions; these events were subsequently validated by review of medical records. Overall, this approach resulted in a follow-up completion rate of 92%. In the remaining 8% of patients, we assessed mortality using the online Social Security Death Index website. Adjudication. To establish the diagnosis of ACS and MACE, an outcome panel of 2 experienced physicians with more than 10 years' experience (1 ED physician [J.T.N] and 1 cardiologist [S.S.]) reviewed patient data forms containing prospectively collected information on the history and nature of chest pain, risk factors, and medical history, as well as medical records pertaining to the hospital admission. The outcome panel was blinded to the findings of coronary CT. Disagreement was resolved by consensus, which included an additional cardiologist (C.C.) (25) . Clinical covariates. We prospectively collected data on demographics, risk factor profile, Thrombolysis In Myocardial Infarction (TIMI) risk score, and clinical course in all patients. Presence of risk factors (i.e., hypertension, hypercholesterolemia, and diabetes mellitus) was established from actual measurements obtained during the hospitalization or related medication use. Medical records were reviewed to obtain results of all diagnostic tests performed during index hospitalization. Statistical analysis. Demographics, traditional risk factors, clinical events, and prevalence of plaque and stenosis as detected by coronary CTA are presented as mean Ϯ SD or median and interquartile range for continuous variables and as percentages for categorical variables.
We determined the utility of coronary CT to guide triage decisions in the ED using 2 different analytic strategies. To determine the accuracy of coronary CTA, we calculated conventional measures of diagnostic accuracy (sensitivity, negative predictive value [NPV], specificity, and positive predictive value [PPV] ) and test-positive and -negative likelihood ratios with 95% confidence intervals (CIs) based on a binomial distribution for the absence of plaque and the absence of significant stenosis for the detection of ACS. The chi-square test was used to compare proportions and measures of diagnostic accuracy between groups. To compare the extent of plaque between subjects with and without ACS, Wilcoxon rank-sum test was applied. Further, we performed multivariate logistic regression modeling to examine the association between the extent of coronary atherosclerotic plaque and the presence of stenosis as detected by coronary CTA with the outcome of ACS. The crude models contained the presence of stenosis as a dichotomous variable, or the extent of plaque, defined as the number of coronary segments with any plaque (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) , as a continuous variable. We then tested whether the association between CT findings and ACS persisted after adjusted for age, sex, and TIMI risk score. Model fit was assessed using c-statistics, equivalent to the area under the receiveroperating characteristic curve (AUC) (26) . The asymptotic 95% CIs for the AUCs were estimated using a nonparaInclusion and Exclusion Criteria metric approach that is closely related to the jackknife technique proposed by DeLong et al. (27) . Also, we performed a 2-sided asymptotic z-test to compare the AUC of the TIMI risk score and the CT finding, in which the standard error of the test statistics was derived from the asymptotic variance covariance (27) . Sample size calculation. The study was designed to assure a high precision of the estimates of diagnostic accuracy. We aimed to demonstrate lower bounds of 95% CIs for NPV above 90%. Based on our initial experience and published data we assumed the following: 12% prevalence of ACS, 90% sensitivity of significant coronary stenosis for ACS, and sensitivity of 90% and specificity of 85% for coronary CTA to detect significant coronary artery stenoses. Thus, a sample size of 400 patients would assure a tight (Ͻ10%) CI of the NPV above 90%. A 2-sided value of p Ͻ 0.05 was considered to indicate statistical significance. All analyses were performed using SAS (version 9.1, SAS Institute Inc., Cary, North Carolina). . In addition, we excluded 231 patients who were ineligible because of interference with standard clinical care (n ϭ 100), who refused participation (n ϭ 124), or who did not complete the CT exam (n ϭ 7). Thus, the study cohort consisted of 368 patients (mean age 52 years, 40% women) ( Table 2) . Clinical outcomes. Overall, 8.4% of patients (31 of 368) had ACS (MI: n ϭ 8, UAP: n ϭ 23), whereas ACS was ruled out in the remaining 337 patients (91.6%). After a mean follow-up of 6.2 Ϯ 2.0 months, none of the 337 subjects without ACS had had a MACE. Coronary CT angiography. The average time to perform a coronary CTA (door-to-door time, including patient preparation) was 16 Ϯ 7 min. The mean actual scan time to obtain the coronary CTA dataset was 14 Ϯ 2 s. Average time for the interpretation of CT images was 9 Ϯ 7 min (range 3 to 29 min).
Results

Patient population.
Prevalence of Plaque and Stenosis and Diagnostic Accuracy of Coronary CTA
By coronary CTA, 50.3% (183 of 368) of these patients were free of CAD, 31.2% (117 of 368) had plaque but no stenosis, and 18.5% had a positive CTA (34 were positive for stenosis and 34 rendered inconclusive assessment). The diagnostic test characteristics for ACS are shown in Table 3 . Coronary atherosclerotic plaque. Because none of the patients without plaque had ACS, sensitivity and NPV were excellent (100%). In contrast, specificity and PPV of the presence of coronary plaque was low to moderate because many patients had plaque but no ACS (PPV 17%, specificity 54%). Notably, the specificity of the presence of coronary plaque for ACS was lower in older subjects owing to high prevalence of plaque (21% vs. 59%, p Ͻ 0.0001, for subjects Ն65 years of age vs. Ͻ65 years of age, respectively). Similar findings were seen for the detection of MI (Table 3) .
Among 185 subjects in whom any coronary plaque was detected, patients with ACS had significantly more plaque (7.2 Ϯ 3.7 segments vs. 4.2 Ϯ 3.4 segments, p Ͻ 0.0001) as compared with subjects without ACS. Similar results were seen for calcified plaque and noncalcified plaque (6.5 Ϯ 3.7 segments vs. 3.6 Ϯ 3.5 segments, p Ͻ 0.0001, and 3.6 Ϯ 3.2 segments vs. 1.8 Ϯ 2.2 segments, p Ͻ 0.0001, respectively). Among 14 subjects (4%) with exclusively noncalcified plaque, only 1 subject developed ACS (1 of 14, 7.1%). Coronary artery stenosis. The absence of significant stenosis had excellent NPV of 98%, but sensitivity was limited Coronary CT and Acute Chest Pain in the ED to 77%, as 7 subjects in whom a stenosis was excluded by coronary CTA had ACS ( Table 3 ). Characteristics of these subjects are detailed in Table 4 . Because a substantial fraction of patients with a positive CT developed ACS ( Fig. 1 ), PPV and specificity were reasonable and very good and higher than for the absence of plaque (PPV 35%, specificity 87%). Similar findings were seen for the detection of MI (Table 3 ). The specificity of the presence of significant stenosis detected by coronary CTA for ACS was lower in older subjects (58% vs. 91%, p Ͻ 0.0001, for subjects Ն65 years of age vs. Ͻ65 years of age, respectively), in whom coronary calcification was more prevalent (84% vs. 39%; p Ͻ 0.0001). The proportion of patients in whom a stenosis could not be definitely excluded in CT was significantly higher among subjects with ACS as compared with subjects without ACS (24 of 31 [77.4%] vs. 44 of 337 [13.1%], p Ͻ 0.0001). Remarkably, 14 of 34 patients who had a significant stenosis detected by CT were not diagnosed with ACS. None of them had a MACE after 6 months. Coronary CT findings for risk stratification. In logistic regression analysis, each additional segment of plaque was associated with a 37% increased risk of having an ACS (odds ratio [OR]: 1.37, 95% CI: 1.25 to 1.51; p Ͻ 0.001), whereas the presence of stenosis was associated with a more than 20-fold increased risk of ACS (OR: 22.8, 95% CI: 9.3 to 56.1; p Ͻ 0.0001). These associations persisted after adjustment for age, sex, and TIMI risk score (OR: 1.28, 95% CI: 1.14 to 1.43; p Ͻ 0.0001 and OR: 11.69, 95% CI: 4.4 to 31.0; p Ͻ 0.0001 for the extent of plaque and the presence of stenosis, respectively). The AUC in receiveroperator curves for the prediction of ACS was higher for both the extent of plaque (AUC 0.88, 95% CI: 0.83 to 0.93) and the presence of stenosis (AUC 0.82, 95% CI: 0.74 to 0.89) as compared to TIMI risk score (AUC 0.63, 95% CI: 0.54 to 0.71) (Fig. 2) . Standard care and CTA findings. On average, patients presented to the ED 6.7 Ϯ 7.4 h (range 0.08 to 24.0 h) after the onset of chest pain. For most of these patients, the hospital course was characterized by obtaining serial troponin measurements and resting ECGs over the first 24 h and stress testing the following day. The average hospital length of stay was 40.5 Ϯ 43.2 h (range 2.7 to 381.4 h). stenosis that improved with intracoronary nitroglycerin; thus, the patient's non-ST-segment elevation MI was attributed to vasospasm. Two patients had exercise treadmill tests, both of which were positive. Thirteen patients had stress (exercise or adenosine) single-positron emission computed tomography (SPECT) imaging, of which 11 were positive, 1 was negative at a submaximal heart rate, and 1 was indeterminate because of significant attenuation artifact. The 1 patient who had a negative submaximal SPECT was found to have significant stenosis on coronary CTA. The 1 patient who had an indeterminate SPECT also had an inconclusive coronary CTA.
Among the 337 patients (91.6%) in whom ACS was excluded, 13 patients underwent selective invasive coronary angiography, none of which revealed significant stenosis. There were 117 patients who underwent exercise treadmill testing. Two exercise treadmill tests were positive: 1 patient was positive for ischemia but negative on subsequent invasive coronary angiography and negative on coronary CTA, and 1 patient was positive but negative on subsequent SPECT and negative on CTA. A total of 137 patients had stress (exercise or adenosine) SPECT imaging, 3 of whom had ischemia on SPECT but no obstructive disease on invasive coronary angiography or coronary CTA.
Discussion
In this blinded observational cohort study, we demonstrate that 50% of patients who presented with acute chest pain to the ED and were at low to intermediate likelihood of ACS had no CAD by coronary CTA, a finding that has 100% NPV but limited PPV for the subsequent diagnoses of ACS and MACE. In addition, our results indicate that although (14, 15) have demonstrated that a negative CT, defined variably as the absence of coronary calcification, the absence of CAD, or the absence of nonsignificant stenosis, has a high negative predictive value for ACS. In addition to confirming these findings, we are able to provide robust estimates of diagnostic accuracy with narrower CIs (lower 95% confidence bound Ͼ85% for NPV) because of our larger sample size. Importantly, in contrast to previous publications, we also demonstrate that the presence of significant stenosis (defined as Ͼ50% luminal narrowing) has reasonable test characteristics for the detection of ACS, although, expectedly, this is not a perfect criterion for ED triage of patients with acute chest pain (sensitivity 77%, n ϭ 7 of 31). Possible explanations are rupture or thrombosis in subcritical (28, 29) or microvascular disease (30) and limited accuracy of coronary CTA to detect stenosis in small-caliber vessels (Ͻ2 mm) (11). Our results suggest that the technique may be less efficient in patients Ͼ65 years of age, as the specificity of the plaque triage criterion is significantly limited because most of these patients will have CAD (59% vs. 21% for patients Ͼ65 vs. Ͻ65 years of age).
In contrast to most published studies, the design of our study permits an unbiased assessment because coronary CTA was not part of standard care, and thus, patient management and subsequent patient outcomes were not affected by CTA (i.e., additional downstream testing such as coronary angiography due to suspected stenosis in CT). As a result, we are able to report the diagnostic accuracy of several CTA patterns of CAD, such as presence of both calcified and noncalcified plaque as well as coronary stenosis Ͻ50% for ACS. Interestingly, a significant stenosis by CT was detected in 14 patients who were deemed to not have ACS based on clinical presentation, ECG, biomarkers, and a negative diagnostic test for ischemia. This suggests that CT is more sensitive in detecting significant luminal narrowing, although the hemodynamic significance is unknown. Because none of these patients had a MACE over the following 6 months, the finding of significant CAD as detected by CT may be longstanding and coincidental, with no relation to the patient's acute clinical presentation in the ED. This finding warrants further research specifically related to the morphologic appearance of these lesions as compared to ACS lesions.
Our data also demonstrate that coronary CTA can risk-stratify patients with acute chest pain and intermediate likelihood of ACS independent of cardiovascular risk factors, TIMI risk score. Although such an analysis is familiar from observational trials using nuclear perfusion imaging at rest in the pre-troponin era (31, 32) , our results suggest that coronary CTA is superior to nuclear perfusion imaging (OR: 3.83; 95% CI: 2.36 to 6.21 for nuclear imaging vs. OR: 8.65; 95% CI: 3.69 to 20.26 for coronary CTA) (33) . This information may guide assessment of the level of care necessary for these patients and, moreover, may improve risk assessment and prevention efforts in patients without ACS who are found to have coronary atherosclerosis. Several studies (34, 35) now support that the presence and extent of CAD is also a powerful predictor of future cardiovascular events.
It appears that there is broad agreement (14, 15, 17 ) that coronary CTA may improve management of patients with acute chest pain. However, our results demonstrate that the strength of coronary CTA is its high negative predictive value for ACS. Half of all patients in our population had no CAD as detected by coronary CTA. In these patients, alternative diagnostic tests such as exercise stress testing or stress nuclear perfusion imaging were positive in up to 20% of cases, reflecting that they have limited specificity as compared to CT (33,36 -38) . Because none of these patients had ACS, they may be directly discharged from the ED without further diagnostic testing or hospital admission. Overall, our results may provide the rationale to establish recommendations for the actual clinical use of cardiac CT in populations with a low or intermediate likelihood of ACS, a population in whom diagnostic imaging tests have been generally recommended (22, 39) .
One of the major limitations of coronary CT is the associated radiation exposure (40) . Reduction of radiation exposure using ECG tube modulation or prospective ECG triggering (41) will greatly facilitate acceptance in clinical practice. Study limitations. This is a single-center study with enrollment limited to weekday daytime hours. However, subjects presenting outside enrollment hours were not significantly different from enrolled subjects with respect to age and sex, which are the strongest predictors of the prevalence of CAD. Because of exclusion of patients with known CAD and renal impairment, very elderly persons are under-represented in this study. In a real-world clinical scenario, many of these patients may be eligible for coronary CTA. Also, we used a CT scanner system from a single manufacturer. However, differences between vendors in the accuracy of coronary CTA for the detection of plaque and stenosis are marginal (11) . In addition, coronary CTA exams in our study were performed by a dedicated research team and interpreted by readers with a high level of expertise in the field, having at least 2 years experience with coronary CTA and more than 800 studies interpreted. Thus, it is possible that our results, including the high reproducibility of CT readings and the small number of inconclusive examinations, may be replicated only in centers with similar levels of expertise.
Conclusions
Both plaque and stenosis by CT predict ACS independent of cardiovascular risk factors or TIMI risk score. In this study, 50% of patients with acute chest pain and low to intermediate likelihood of ACS are free of CAD by CT and have no ACS. Given the large number of such patients, early coronary CTA may significantly improve patient management in the ED.
